Related Experiment Videos
Anticerebral antibodies in functional psychoses
1Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.
Biological Psychiatry
|February 15, 1991
Summary
Researchers investigated anticerebral antibodies in individuals with schizophrenia and depression. A higher prevalence of nerve cell antibodies was found in schizophrenics compared to depressives and healthy controls.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Autoimmune processes are increasingly implicated in psychiatric disorders.
- Antibodies targeting brain components may serve as biomarkers for neurological and psychiatric conditions.
Purpose of the Study:
- To investigate the presence and patterns of anticerebral antibodies in patients diagnosed with schizophrenia and depression.
- To compare antibody prevalence between patient groups and healthy volunteers.
Main Methods:
- Indirect immunofluorescence was used to detect antibodies against rabbit brain tissue.
- Sera from 44 schizophrenics, 52 depressives (DSM-III-R diagnosed), and 54 healthy controls were analyzed.
- Antibody staining patterns (nerve cells, blood vessels, nuclei, glial cells) were classified, and absorption studies were performed.
Main Results:
- Type A antibodies (targeting nerve cells) were detected in 34.1% of schizophrenics, significantly higher than in depressives (3.8%) and controls (0%).
- Absorption with rabbit liver acetone powder reduced the prevalence in schizophrenics to 27.3% and in depressives to 1.9%, indicating some specificity.
- Other staining patterns (B, C, D) showed no significant differences between groups.
Conclusions:
- The study suggests a potential association between anticerebral antibodies, specifically those targeting nerve cells, and schizophrenia.
- These antibodies may represent a biomarker for a subset of schizophrenia patients.
- Further research is warranted to elucidate the role of these antibodies in the pathophysiology of schizophrenia.